A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma-Reference-Cited by-同舟云学术

A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma

Published:2014-03-27 Issue:1 Volume:166 Page:118-129
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Russo Filippo¹,Corazzelli Gaetano¹,Frigeri Ferdinando¹,Capobianco Gaetana¹,Aloj Luigi²,Volzone Francesco¹,De Chiara Annarosaria³,Bonelli Annamaria⁴,Gatani Tindaro⁵,Marcacci Gianpaolo¹,Donnarumma Daniela¹,Becchimanzi Cristina¹,de Lutio Elisabetta⁶,Ionna Franco⁷,De Filippi Rosaria⁸,Lastoria Secondo²,Pinto Antonello¹

Affiliation:

1. Haematology-Oncology and Stem Cell Transplantation Unit; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

2. Nuclear Medicine; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

3. Pathology; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

4. Cardiology; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

5. Respiratory Medicine; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

6. Radiology; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

7. Head and Neck Surgery Units; National Cancer Institute; Fondazione ‘G. Pascale’; IRCCS; Naples Italy

8. Department of Clinical Medicine and Surgery; Federico II University; Naples Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12862/fullpdf

Reference69 articles.

1. Involved-field radiotherapy for advanced Hodgkin's lymphoma;Aleman;New England Journal of Medicine,2003

2. BEACOPPescalated versus ABVD in advanced Hodgkin's lymphoma;Andre;The Lancet Oncology,2013

3. Interim analysis of the randomized Eortc/Lysa/Fil intergroup H10 trial on early PET-scan driven treatment adaptation in stage I/II Hodgkin Lymphoma;André;Blood,2012

4. Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma;Avigdor;Annals of Oncology,2010

5. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma;Bauer;Cochrane Database Systematic Review,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term efficacy and safety of dose‐dense and dose‐intense ABVD without consolidation radiotherapy in patients with advanced Hodgkin lymphoma: A 15‐year follow‐up of the ABVD_DD‐DI phase II study;British Journal of Haematology;2024-08

2. Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study;British Journal of Haematology;2022-07-12

3. Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi;Annals of Hematology;2021-07-30

4. Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review;Expert Review of Hematology;2020-08-02

5. Neutropenia during frontline treatment of advanced Hodgkin lymphoma: Incidence, risk factors, and management;Critical Reviews in Oncology/Hematology;2019-06